Product Wiki · Recalls · EU Safety Gate (RAPEX)

Lait éclaircissant Soin Hydratant Nourrissant CAROTTE — recall A12/00041/22

EU Safety Gate (RAPEX) · France · 2022-01-14 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/00041/22
Date of alert
2022-01-14
Country / jurisdiction
France
Risk level
Serious risk
Risk type
Chemical
Brand
Pr. Francoise Bedon Paris
Product category
Cosmetics
Product type
Skin-lightening milk
Barcode (EAN/GTIN)
3760091560735
Reported risk: Le produit contient de l'hydroquinone (valeur mesurée 4,4 % en poids). L'hydroquinone peut provoquer une irritation cutanée et une dermatite. Le produit n'est pas conforme au règlement sur les produits cosmétiques.
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Removal of this product listing by the online marketplace
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Lait éclaircissant Soin Hydratant Nourrissant CAROTTE

Risk Description (original English): The product contains hydroquinone (measured value 4.4% by weight). Hydroquinone can cause skin irritation and dermatitis.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10005048

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.